NASDAQ:GLMD | Profit Breakdown | Galmed Pharmaceuticals Ltd.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$2.72M
2026-03-31-$1.91M
2025-12-31-$4.82M
2025-09-30-$1.89M
2025-06-30-$2.5M
2025-03-31-$1.1M
2024-12-31-$3.21M
2024-09-30-$1.91M
2024-06-30-$1.12M
2024-03-31-$1.28M
2023-06-30-$1.59M
2023-03-31-$1.83M
2022-06-30-$3.73M
2022-03-31-$6.14M
2021-06-30-$8.4M
2021-03-31-$8.91M
2020-06-30-$5.82M-$5.53M
2020-03-31-$6.06M
2019-06-30$0.00-$4.7M-$4.17M
2019-03-31-$3.49M
2018-06-30$270,000.00-$2.69M-$2.69M
2018-03-31-$2.51M
2017-06-30$270,000.00-$2.69M-$2.69M
2016-06-30$0.00-$4.31M-$4.31M
2015-06-30-$2.35M-$2.35M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$10.31M
2024-12-31$7.52M-$7.52M
2023-12-31$6.91M-$6.91M
2022-12-31$17.87M-$17.87M
2021-12-31-$32.47M-$32.47M
2020-12-31$0.00-$30.21M-$28.77M-$28.77M
2019-12-31$0.00-$22.38M-$20.46M-$20.46M
2018-12-31$2.04M-$10.72M-$9.78M-$9.86M
2017-12-31$1.09M-$12.36M-$12.3M-$12.3M
2016-12-31$467,000.00-$16.85M-$16.95M
2015-12-31$0.00-$10.62M-$10.62M
2014-12-31$0.00-$9.1M-$9.1M
2013-12-31-$17.48M-$17.49M
2012-12-31-$3.14M-$3.15M